Literature DB >> 19119143

Suppression of 2,3-oxidosqualene cyclase by high fat diet contributes to liver X receptor-alpha-mediated improvement of hepatic lipid profile.

Huaixin Dang1, Yan Liu, Wei Pang, Chenghong Li, Nanping Wang, John Y-J Shyy, Yi Zhu.   

Abstract

The liver X receptors (LXRs) sense oxysterols and regulate genes involved in cholesterol metabolism. Synthetic agonists of LXRs are potent stimulators of fatty acid synthesis, which is mediated largely by sterol regulatory element-binding protein-1c (SREBP-1c). Paradoxically, an improved hepatic lipid profile by LXR was observed in mice fed a Western high fat (HF) diet. To explore the underlying mechanism, we administered mice normal chow or an HF diet and overexpressed LXRalpha in the liver. The HF diet with tail-vein injection of adenovirus of LXRalpha increased the expression of LXR-targeted genes involved in cholesterol reverse transport but not those involved in fatty acid synthesis. A similar effect was also observed with the use of 22R-hydroxycholesterol, an LXR ligand, in cultured hepatocytes. Consequently, SREBP-1c maturation was inhibited by the HF diet, which resulted from the induction of Insig-2a. Importantly, increased cholesterol level suppressed the expression of 2,3-oxidosqualene cyclase (OSC), which led to an increase in endogenous LXR ligand(s). Furthermore, siRNA-mediated knockdown of OSC expression enhanced LXR activity and selectively up-regulated LXR-targeted genes involved in cholesterol reverse transport. Thus, down-regulation of OSC may account for a novel mechanism underlying the LXR-mediated lipid metabolism in the liver of mice fed an HF diet.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19119143      PMCID: PMC2649084          DOI: 10.1074/jbc.M803702200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Identification of macrophage liver X receptors as inhibitors of atherosclerosis.

Authors:  Rajendra K Tangirala; Eric D Bischoff; Sean B Joseph; Brandee L Wagner; Robert Walczak; Bryan A Laffitte; Chris L Daige; Diane Thomas; Richard A Heyman; David J Mangelsdorf; Xuping Wang; Aldons J Lusis; Peter Tontonoz; Ira G Schulman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-22       Impact factor: 11.205

Review 2.  Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis.

Authors:  J D Horton
Journal:  Biochem Soc Trans       Date:  2002-11       Impact factor: 5.407

3.  Liver-specific mRNA for Insig-2 down-regulated by insulin: implications for fatty acid synthesis.

Authors:  Daisuke Yabe; Ryutaro Komuro; Guosheng Liang; Joseph L Goldstein; Michael S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-06       Impact factor: 11.205

4.  Adenovirus-mediated overexpression of dominant-negative mutant of c-Jun prevents intercellular adhesion molecule-1 induction by LDL: a critical role for activator protein-1 in endothelial activation.

Authors:  N Wang; L Verna; A Ballard; Y Zhu; M B Stemerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-09       Impact factor: 8.311

5.  27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells.

Authors:  X Fu; J G Menke; Y Chen; G Zhou; K L MacNaul; S D Wright; C P Sparrow; E G Lund
Journal:  J Biol Chem       Date:  2001-08-14       Impact factor: 5.157

6.  Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins.

Authors:  Daisuke Yabe; Michael S Brown; Joseph L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-19       Impact factor: 11.205

7.  RNA interference targeting Fas protects mice from fulminant hepatitis.

Authors:  Erwei Song; Sang-Kyung Lee; Jie Wang; Nedim Ince; Nengtai Ouyang; Jun Min; Jisheng Chen; Premlata Shankar; Judy Lieberman
Journal:  Nat Med       Date:  2003-02-10       Impact factor: 53.440

8.  Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER.

Authors:  Tong Yang; Peter J Espenshade; Michael E Wright; Daisuke Yabe; Yi Gong; Ruedi Aebersold; Joseph L Goldstein; Michael S Brown
Journal:  Cell       Date:  2002-08-23       Impact factor: 41.582

9.  Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesis.

Authors:  Guoqing Cao; Yu Liang; Carol L Broderick; Brian A Oldham; Thomas P Beyer; Robert J Schmidt; Youyan Zhang; Keith R Stayrook; Chen Suen; Keith A Otto; Anne R Miller; Jiannong Dai; Patricia Foxworthy; Hong Gao; Timothy P Ryan; Xian-Cheng Jiang; Thomas P Burris; Patrick I Eacho; Garret J Etgen
Journal:  J Biol Chem       Date:  2002-10-31       Impact factor: 5.157

10.  T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice.

Authors:  Naoki Terasaka; Ayano Hiroshima; Tadashi Koieyama; Naoko Ubukata; Yuka Morikawa; Daisuke Nakai; Toshimori Inaba
Journal:  FEBS Lett       Date:  2003-02-11       Impact factor: 4.124

View more
  6 in total

1.  Cholesterol synthesis-related enzyme oxidosqualene cyclase is required to maintain self-renewal in primary erythroid progenitors.

Authors:  C Mejia-Pous; F Damiola; O Gandrillon
Journal:  Cell Prolif       Date:  2011-10       Impact factor: 6.831

2.  Dysregulation of Plasmalogen Homeostasis Impairs Cholesterol Biosynthesis.

Authors:  Masanori Honsho; Yuichi Abe; Yukio Fujiki
Journal:  J Biol Chem       Date:  2015-10-13       Impact factor: 5.157

3.  Reduced VLDL clearance in Apoe(-/-)Npc1(-/-) mice is associated with increased Pcsk9 and Idol expression and decreased hepatic LDL-receptor levels.

Authors:  Minako Ishibashi; David Masson; Marit Westerterp; Nan Wang; Scott Sayers; Rong Li; Carrie L Welch; Alan R Tall
Journal:  J Lipid Res       Date:  2010-06-18       Impact factor: 5.922

Review 4.  Controlling cholesterol synthesis beyond 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR).

Authors:  Laura J Sharpe; Andrew J Brown
Journal:  J Biol Chem       Date:  2013-05-21       Impact factor: 5.157

5.  2,3-Oxidosqualene cyclase protects liver cells from the injury of intermittent hypoxia by regulating lipid metabolism.

Authors:  Yue-Qiao Zhen; Yu-Min Wu; Yan-Hong Sang; Yan Wang; Qiu-Yan Song; Ling Yu; Xiao-Juan Rao; Rui-Hong Dong
Journal:  Sleep Breath       Date:  2015-04-09       Impact factor: 2.816

6.  Group X secretory phospholipase A2 negatively regulates ABCA1 and ABCG1 expression and cholesterol efflux in macrophages.

Authors:  Preetha Shridas; William M Bailey; Florence Gizard; Rob C Oslund; Michael H Gelb; Dennis Bruemmer; Nancy R Webb
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-10       Impact factor: 8.311

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.